Publications Innovations in Oral Therapies for Inflammatory Bowel Disease Citation Ma C, Battat R, Dulai PS, Parker CE, Sandborn WJ, Feagan BG, Jairath V. Innovations in Oral Therapies for Inflammatory Bowel Disease. Drugs. 2019 Aug;79(12):1321-1335. doi: 10.1007/s40265-019-01169-y. PMID: 31317509. Abstract Prior to the biologic era, the medical management of patients with inflammatory bowel disease (IBD) was dominated by the use of aminosalicylates, corticosteroids, and immunosuppressants. Tags Adverse Effects, Anti-Inflammatory Agents Non-Steroidal, Drug Therapy, Heterocyclic Compounds 3-Ring, IBD, Indans, Inflammatory Bowel Disease, Janus kinase inhibitors, Mesalamine, Oxadiazoles, Phosphodiesterase Inhibitors, Piperidines, Pyrimidines, Pyrroles, Receptors Lysosphingolipid, therapeutic use, Triazoles Read More
